Ecora Resources PLC (TSX:ECOR:CA ) Q2 2025 Earnings Call September 9, 2025 11:00 AM EDT Company Participants Marc Lafleche - CEO & Executive Director Kevin Flynn - CFO & Executive Director Presentatio
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) earlier this week reported its half-year results, highlighting strong momentum in its base metals and critical minerals portfolio. The company sai
ROCKAWAY, N.J., Sept. 05, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today the departure of Peter Cuneo from t
ROCKAWAY, N.J., Sept. 04, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (NASDAQ: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today its partnership with Greg Buttle, f

Ecora Resources adds South32 nominee to its board

03:23am, Thursday, 04'th Sep 2025
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) announced it will appoint Michael Falconer as a non-executive director, effective 9 September, as nominee of shareholder South32 Ltd (LSE:S32, A
Ecora Resources PLC (TSX:ECOR:CA ) Q2 2025 Earnings Call September 3, 2025 9:00 AM EDT Company Participants Geoff Callow - Head of Investor Relations Marc Lafleche - CEO & Executive Director Kevin Fly
ROCKAWAY, N.J., Sept. 03, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Elena Bonfiglioli, an accompli
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) chief executive Marc Bishop Lafleche told investors that 2025 is proving to be a significant year, as the investment company continues to piv
ROCKAWAY, N.J., Sept. 02, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, announced today that management will participate at
Ecora Resources PLC (LSE:ECOR, TSX:ECOR, OTCQX:ECRAF) has struck a deal to sell its royalty interest in the Dugbe gold project in Liberia for up to $20 million, as it continues to streamline its portf
ROCKAWAY, N.J., Aug. 12, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (Nasdaq: ECOR), a commercial-stage bioelectronic medicine and wellness company, today announced that Kelly Benning has been hired as
electroCore, Inc. (NASDAQ:ECOR ) Q2 2025 Earnings Conference Call August 6, 2025 4:30 PM ET Company Participants Daniel S. Goldberger - CEO & Director Joshua S.
electroCore, Inc. (ECOR) came out with a quarterly loss of $0.35 per share versus the Zacks Consensus Estimate of a loss of $0.32. This compares to a loss of $0.38 per share a year ago.

electroCore (ECOR) Q2 Revenue Jumps 20%

05:57pm, Wednesday, 06'th Aug 2025
electroCore (ECOR 1.02%), a medical device company focused on non-invasive bioelectronic therapies, released its second quarter 2025 financial results on August 6, 2025. The release showed GAAP quarte
Net sales of $7.4 million increased 20% vs. Q2'2024; YTD net sales of $14.1 million increased 22% vs. first half of 2024
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE